Carla Scaramella
About Carla Scaramella
Carla Scaramella is a Clinical Site Manager at Bristol-Myers Squibb in New York with over 9 years of experience at the company. She has extensive experience in clinical research and a background in pharmacy and commercial assistance.
Current Role at Bristol-Myers Squibb
Carla Scaramella currently serves as a Clinical Site Manager at Bristol-Myers Squibb in New York, New York, United States. She holds this position with over 9 years of experience at the company. In this role, she oversees various clinical trial operations at site levels, ensuring compliance and adherence to protocols.
Previous Experience at Bristol-Myers Squibb
Prior to her current role, Carla Scaramella worked as a Clinical Site Monitor at Bristol-Myers Squibb from 2011 to 2014 for three years. In this capacity, she was responsible for monitoring clinical trials, managing site communications, and ensuring the quality and accuracy of trial data.
Career at IQVIA
Carla Scaramella has substantial experience in clinical research from her time at IQVIA, where she worked in various capacities. She served as a Senior Clinical Research Associate for nine months from 2010 to 2011 and as a Clinical Research Associate from 2007 to 2010 for three years. Her roles at IQVIA involved coordinating and overseeing clinical trial activities and maintaining compliance with regulatory requirements.
Background in Pharmacy
Carla Scaramella has a strong background in pharmacy, having worked as an Auxiliar de Farmacia at Farmacity from 2001 to 2007 for six years. In this role, she was involved in various pharmacy-related activities, providing support to pharmacists and assisting customers with their medication needs.
Educational Background
Carla Scaramella has an extensive educational background, including studies at several institutions. She studied at the University of Buenos Aires from 1999 to 2006, the Universidad del Salvador in 2007, and the Universidad de Belgrano in 2011. Additionally, she attended the University of Cambridge twice, once in 1996 and again in 1998.